Stay updated with breaking news from Laurus Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“We are very, very positive on the CDMO and CRO space within pharma, which we think is a very structural trend over the next 5 to 10 to 15 years. The CDMO space is a very small space right now. But what we saw in IT, we could see in the CDMO space, specific to pharma.”
“If you are betting into the jewellery sector, the period between Dhuleti and Dhanteras is the best time to accumulate these particular stocks and the moment the festive season starts, that is the best time to book some profit. That is how one can make maximum gain in this kind of business.”
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 460 in its research report dated October 20, 2023.
Banking remains the hot favourite among fund managers and that seems to be part of the problem. If most people have already become believers of the story, finding new faithfuls or converts becomes a tough task
“There is going to be a capital infusion of about Rs 20,000 to 22,000 crore in Indiabulls. And that would be at a significant premium and will be book value accretive. Post that, once there is a clean management and a substantial capital, they have a very decent book size.”